Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Research and development spending
3Y CAGR
+2.0%/yr
vs +24.5%/yr prior
5Y CAGR
+12.7%/yr
Recent deceleration
Acceleration
-22.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $750.00M | +7.5% |
| 2024 | $697.87M | +7.6% |
| 2023 | $648.45M | -8.1% |
| 2022 | $705.79M | +42.0% |
| 2021 | $497.15M | +20.6% |
| 2020 | $412.08M | +15.3% |
| 2019 | $357.36M | +21.6% |
| 2018 | $294.00M | +26.9% |
| 2017 | $231.64M | +26.4% |
| 2016 | $183.20M | - |